Some good results from other tests on heart issues using stem cells.
https://www.dicardiology.com/content/stem-cell-therapy-improved-quality-life-patients-microvascular-dysfunction
"This was a proof of concept trial to evaluate the safety and efficacy of CD34+ stem cells administered via intracoronary infusion for CMD patients with abnormal coronary flow reserve of less than 2.5,” said Timothy D. Henry, M.D., MSCAI, lead author of the study and SCAI vice president. “Our results demonstrate a significant improvement in coronary flow reserve with a single intracoronary infusion of CD34+ cells as well as a significant improvement in angina and quality of life.”
- Forums
- ASX - By Stock
- Cell Therapy News/Articles
Some good results from other tests on heart issues using stem...
-
- There are more pages in this discussion • 15,291 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.02 |
Change
0.065(6.84%) |
Mkt cap ! $1.124B |
Open | High | Low | Value | Volume |
95.5¢ | $1.03 | 95.0¢ | $5.562M | 5.551M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
17 | 53986 | $1.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.02 | 20390 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
20 | 38613 | 1.010 |
7 | 59090 | 1.005 |
10 | 64956 | 1.000 |
6 | 27169 | 0.995 |
4 | 38725 | 0.990 |
Price($) | Vol. | No. |
---|---|---|
1.015 | 35641 | 28 |
1.020 | 270284 | 28 |
1.025 | 109459 | 14 |
1.030 | 206563 | 15 |
1.035 | 210122 | 9 |
Last trade - 15.26pm 30/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online